Tag: platform trials

Digital Tools, Platforms and Data Lakes to Power Adaptive & Platform Trials in R&D Adaptive and platform trials represent a significant evolution in the methodology of clinical trials. Their flexible design allows researchers to evaluate treatments and therapies more efficiently than traditional methods. This article serves as a comprehensive tutorial targeted at clinical operations, regulatory…

Read More “Digital Tools, Platforms and Data Lakes to Power Adaptive & Platform Trials in R&D” »

KPIs, Dashboards and Analytics to Measure Adaptive & Platform Trials in R&D Success In the landscape of clinical research, the importance of utilizing key performance indicators (KPIs), advanced dashboards, and comprehensive analytics cannot be overstated, especially for adaptive and platform trials. These methodologies, pivotal for optimizing resources and enhancing the strategic decision-making process, have emerged…

Read More “KPIs, Dashboards and Analytics to Measure Adaptive & Platform Trials in R&D Success” »

Global Regulatory Expectations Shaping Adaptive & Platform Trials in R&D in the US, EU and UK The landscape of clinical research is evolving rapidly, particularly with the advent of innovative trial designs such as adaptive and platform trials. These methodologies offer enhanced flexibility and efficiency, enabling researchers to respond dynamically to emerging data. As regulatory…

Read More “Global Regulatory Expectations Shaping Adaptive & Platform Trials in R&D in the US, EU and UK” »

Partnering, Outsourcing and Alliances to Scale Adaptive & Platform Trials in R&D Partnering, Outsourcing and Alliances to Scale Adaptive & Platform Trials in R&D In the rapidly evolving field of clinical research, particularly concerning adaptive and platform trials, understanding the mechanisms of partnering, outsourcing, and forming alliances is critical for organizations involved in pharmaceutical R&D….

Read More “Partnering, Outsourcing and Alliances to Scale Adaptive & Platform Trials in R&D” »

Common Pitfalls in Adaptive & Platform Trials in R&D—and How to Avoid Costly Rework In the evolving landscape of clinical research, adaptive and platform trials represent a paradigm shift that promises enhanced efficiency and innovative approaches to drug development. However, these methodologies are not without their challenges. This article aims to provide clinical operations, regulatory…

Read More “Common Pitfalls in Adaptive & Platform Trials in R&D—and How to Avoid Costly Rework” »

Adaptive & Platform Trials in R&D: Strategic Playbook for Modern Pharma R&D Adaptive & Platform Trials in R&D: Strategic Playbook for Modern Pharma R&D Introduction to Adaptive and Platform Trials Adaptive and platform trials represent innovative approaches in the realm of clinical research, particularly in the context of pharmaceutical R&D. These methodologies allow researchers to…

Read More “Adaptive & Platform Trials in R&D: Strategic Playbook for Modern Pharma R&D” »

How to Design Adaptive & Platform Trials in R&D That Accelerates Time-to-Proof-of-Concept How to Design Adaptive & Platform Trials in R&D That Accelerates Time-to-Proof-of-Concept In the rapidly evolving landscape of pharmaceutical research and development (R&D), the design of clinical trials must adapt to the increasing complexity of drug development and patient populations. Adaptive and platform…

Read More “How to Design Adaptive & Platform Trials in R&D That Accelerates Time-to-Proof-of-Concept” »

Adaptive & Platform Trials in R&D in Practice: Case Studies, Workflows and Governance Models Adaptive and platform trials represent a significant advancement in the landscape of clinical research, allowing for more flexible and efficient drug development processes. This tutorial will provide a comprehensive overview of these approaches, discussing their benefits, workflows, governance models, and illustrative…

Read More “Adaptive & Platform Trials in R&D in Practice: Case Studies, Workflows and Governance Models” »

High-Impact Adaptive & Platform Trials in R&D Tactics That De-Risk Clinical Development High-Impact Adaptive & Platform Trials in R&D Tactics That De-Risk Clinical Development In recent years, there has been a pronounced shift towards more adaptive and platform clinical trial designs in pharmaceutical research and development (R&D). Such methodologies are essential not only for optimizing…

Read More “High-Impact Adaptive & Platform Trials in R&D Tactics That De-Risk Clinical Development” »

Integrating Adaptive & Platform Trials in R&D With Clinical Development, CMC and Market Access In recent years, the pharmaceutical R&D landscape has experienced significant evolution, primarily through the increasing implementation of adaptive and platform trials. These methodologies offer distinct advantages in terms of efficiency, flexibility, and appropriateness for tackling complex diseases, such as ovarian cancer….

Read More “Integrating Adaptive & Platform Trials in R&D With Clinical Development, CMC and Market Access” »